“Don’t Phos Over Tau”: recent developments in clinical biomarkers and therapies targeting tau phosphorylation in Alzheimer’s disease and other tauopathies

Phosphorylation is one of the most prevalent post-translational modifications found in aggregated tau isolated from Alzheimer ’s disease (AD) patient brains. In tauopathies like AD, increased phosphorylation or...

Source: Molecular Neurodegeneration - June 5, 2021 Category: Neurology Authors: Yuxing Xia, Stefan Prokop and Benoit I. Giasson Tags: Review Source Type: research